BIOMAT Database Logo BIOMAT Database Logo

Angiotensin-II-stimulated release of thromboxane A2 and prostacyclin (PGI2) in isolated, perfused kidneys of spontaneously hypertensive rats. 1979

Y Shibouta, and Y Inada, and Z Terashita, and K Nishikawa, and S Kikuchi, and K Shimamoto

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

Y Shibouta, and Y Inada, and Z Terashita, and K Nishikawa, and S Kikuchi, and K Shimamoto
Low concentrations of angiotensin II unmask vasoconstrictory alpha 2-adrenoceptors in isolated perfused kidneys of spontaneously hypertensive rats.
December 1995, Cardiovascular research,
Y Shibouta, and Y Inada, and Z Terashita, and K Nishikawa, and S Kikuchi, and K Shimamoto
Effects of naftidrofuryl on isolated perfused kidneys of spontaneously hypertensive rats.
October 1993, Clinical and experimental pharmacology & physiology,
Y Shibouta, and Y Inada, and Z Terashita, and K Nishikawa, and S Kikuchi, and K Shimamoto
Prostacyclin and thromboxane A2 release in isolated rat lungs.
January 1982, Prostaglandins,
Y Shibouta, and Y Inada, and Z Terashita, and K Nishikawa, and S Kikuchi, and K Shimamoto
Vascular reactivity of isolated perfused kidneys from normotensive, renal hypertensive and spontaneously hypertensive rats.
January 1978, The Chinese journal of physiology,
Y Shibouta, and Y Inada, and Z Terashita, and K Nishikawa, and S Kikuchi, and K Shimamoto
Prostacyclin (PGI2) activity in rat kidney-stimulated by angiotensin II.
April 1979, Experimental and molecular pathology,
Y Shibouta, and Y Inada, and Z Terashita, and K Nishikawa, and S Kikuchi, and K Shimamoto
Exaggerated response to electrical nerve stimulation of angiotensin II release in isolated perfused hind legs of spontaneously hypertensive rats.
January 1991, Clinical and experimental hypertension. Part A, Theory and practice,
Y Shibouta, and Y Inada, and Z Terashita, and K Nishikawa, and S Kikuchi, and K Shimamoto
Vascular reactivity to angiotensin II alone or combined with a thromboxane A2 mimetic in the isolated perfused kidney of Lyon hypertensive rats.
February 2002, Fundamental & clinical pharmacology,
Y Shibouta, and Y Inada, and Z Terashita, and K Nishikawa, and S Kikuchi, and K Shimamoto
Vascular reactivity of isolated perfused kidneys from male and female spontaneously hypertensive rats.
December 1977, Circulation research,
Y Shibouta, and Y Inada, and Z Terashita, and K Nishikawa, and S Kikuchi, and K Shimamoto
Prostacyclin (PGI2) and thromboxane (Tx) A2: mediators of wound healing.
July 1987, Israel journal of medical sciences,
Y Shibouta, and Y Inada, and Z Terashita, and K Nishikawa, and S Kikuchi, and K Shimamoto
Renal thromboxane A2 release stimulated by angiotensin II in the hypoperfused canine kidney.
January 1987, Advances in prostaglandin, thromboxane, and leukotriene research,
Copied contents to your clipboard!